M&A - Battery Ventures XIV, L.P.
Form Type: SCHEDULE 13D
Filing Date: 2025-06-30
Corporate Action: Merger
Type: Update
Accession Number: 000141588925018509
Filing Summary: On June 23, 2025, Battery Ventures XIV, L.P. and its affiliates entered into a Merger Agreement with Bethpage Parent, Inc. and its wholly owned subsidiary, which will result in the merger of the subsidiary with Enzo Biochem, Inc. The Issuer will survive the Merger as a wholly owned subsidiary of Bethpage. The Reporting Persons collectively hold a beneficial ownership of 11,575,824 shares of the Issuer's common stock, including shares associated with stock options and restricted stock units. The agreement includes Voting Agreements where certain shareholders have committed to vote their shares in favor of the Merger. This transaction represents a strategic acquisition for Bethpage, positioning it to enhance its operations in the life sciences sector. The details of the Merger Agreement and Voting Agreements are incorporated as Exhibits 99.2 and 99.3 respectively, and outline the commitments made by the parties involved regarding the transaction.
Additional details:
Reporting Persons: Battery Ventures XIV, L.P.
Reporting Persons: Battery Ventures XIV-EF, L.P.
Reporting Persons: Battery Investment Partners XIV, L.P.
Reporting Persons: Battery Partners XIV, L.P.
Reporting Persons: Battery Partners GP XIV, LLC
Reporting Persons: Neeraj Agrawal
Reporting Persons: Michael M. Brown
Reporting Persons: Morad Elhafed
Reporting Persons: Jesse Feldman
Reporting Persons: Russell L. Fleischer
Reporting Persons: Roger H. Lee
Reporting Persons: Zachary Smotherman
Reporting Persons: Chelsea R. Stoner
Reporting Persons: Dharmesh Thakker
Merger Parties: Bethpage Parent, Inc.
Merger Parties: Bethpage Merger Sub, Inc.
Ownership Percentage: 21.8
Principal Office Address: One Marina Park Drive, Suite 1100, Boston, MA 02210
Common Stock Value: $0.01
Comments
No comments yet. Be the first to comment!